Through enrichment analysis, it was found that PIEZO2 promotes the development of GC through fault processes such as immune response, regulation of cell–matrix, and inflammatory response, so targeting PIEZO2 may be a potential target for GC therapy. Here, PIEZO2 is linked to gastric cancer.